EMERGING BIOTECH
Launch with Confidence
and Speed
Getting your innovation to
patients, faster.
Get Your Launch Readiness Review
The Rise of
First-Time Launchers
50%
of all product launches will be by pre-commercial companies by 2025
The Execution
Challenge
39%
of first-time launchers achieve
their sales forecast
Pre-Commercial Success
Starts with Digital
70%
of biotechs launch their first
brands with Veeva
The European
Opportunity
35%
of revenue from international drug launches come from outside the U.S.

Four Steps to Achieve Launch Excellence

Learn how biotechs accelerate their first drug launches with data, software, and consulting.

Download eBook Watch a Demo
“Veeva's end-to-end solution was the foundation for our pre-launch and launch success, allowing us to focus on refining our strategy and not integrating systems.”

Baptiste Omont, Director, Team Leader Commercial Systems, Idorsia Pharmaceuticals

Learn How to Succeed in Your Launch Strategy, From Planning to Efficient Commercial Execution

Launching innovative new medicines at Idorsia with Veeva Commercial Cloud Read the Story
Effective pre-launch planning and digital-first commercial execution at Impel Neuropharma Read the Story
Partnering to build Axsome’s digital-centric commercialization platform Read the Story

Solutions for Emerging Biotech

Veeva's phased approach drives successful launches.

Veeva Business Consulting

Combine business strategy, data, and technology to drive your launch to success.

Veeva Link

Accelerate insights, precision engagement, and scientific awareness.

CRM Suite

Set the foundations for digital-first customer engagement journeys for your commercial and medical field teams.

Vault PromoMats

Launch, optimize, and scale content with speed.

Veeva OpenData

Power commercial operations with integrated customer reference data.

If you would like more information, please contact us.

Contact Us